Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).

Sci Rep · 2019 · PMC6375935 · PMID 30765854

Europe PMC DOI

hedged sentence

0.0687

closest p · 1.4× alpha

0.0687

boldest claim

The sentences

a strong trendp = 0 . 0687so close (0.05 < p ≤ 0.1)

On the other hand, the pan IR700 + tra IR700 with NIR light demonstrated a strong trend towards greater tumor growth inhibition on Day 28 compared to the tra IR700 with NIR light group ( p = 0 . 0687 ; Mann-Whitney U test).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.